SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001600132-18-000104
Filing Date
2018-06-25
Accepted
2018-06-25 16:51:02
Documents
4
Effectiveness Date
2018-06-25

Document Format Files

Seq Description Document Type Size
1 S-8 s-8june2018.htm S-8 77069
2 EXHIBIT 5.1 s-8june2018exhibit51.htm EX-5.1 12540
3 EXHIBIT 23.2 s-8june2018exhibit232.htm EX-23.2 2870
4 mintzlevina09.jpg GRAPHIC 117377
  Complete submission text file 0001600132-18-000104.txt   255245
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225871 | Film No.: 18917514
SIC: 2834 Pharmaceutical Preparations